Press Releases

Date Title and Summary
Toggle Summary Capnia Announces Private Placement of Up to $13.8 Million of Convertible Preferred Stock
REDWOOD CITY, Calif. , June 29, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that it has entered into an agreement with a
Toggle Summary Capnia Expands Commercial Launch of Serenz® Allergy Relief to Ireland
- Pilot Program to Include 25 Community Pharmacies - REDWOOD CITY, Calif. , June 15, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today
Toggle Summary Capnia Announces Exclusive Distribution Agreement for CoSense® End-Tidal Carbon Monoxide Monitor in India
-Agreement represents continued expansion of CoSense outside the US- REDWOOD CITY, Calif. , June 07, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical
Toggle Summary Capnia to Present at 2016 Marcum MicroCap Conference
REDWOOD CITY, Calif. , May 25, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar , M.D., Chief Executive
Toggle Summary Capnia Reports First Quarter 2016 Financial Results
-Early 2016 Marked by Commencement of Serenz® Sales to European Pharmacies and New Global Distribution Agreements for CoSense® - REDWOOD CITY, Calif. , May 10, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative
Toggle Summary Capnia to Present at the Joseph Gunnar “Pioneers 2016” Conference
REDWOOD CITY, Calif. , April 27, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that Anish Bhatnagar , M.D., Chief Executive
Toggle Summary Capnia Commences Serenz® Allergy Relief Product Sales in Europe
   - Launch facilitated by Agreements with United Kingdom ( UK )-based pharmacy chains - - Novel product for nasal allergies available in more than 150 retail pharmacy locations - REDWOOD CITY, Calif. , April 26, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc.
Toggle Summary Capnia Announces Presentation of CoSense® and Other Pipeline Candidate Data at the 2016 Pediatric Academic Societies Annual Meeting
REDWOOD CITY, Calif. , April 20, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced five posters and one oral presentation relating to
Toggle Summary Capnia Names Rajen Dalal to Board of Directors
Appointment Adds Significant Leadership Experience in Medical Devices and Diagnostics REDWOOD CITY, Calif. , April 18, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing
Toggle Summary Capnia Reports Fourth Quarter and Full Year 2015 Financial Results
-Company to Commence Pilot Sales of Serenz® to European Pharmacies in 2Q 2016- -Recently Announced CoSense® Distribution Agreements Covering the U.S. and China - REDWOOD CITY, Calif. , March 24, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and